Phytanic acidPhytanic acid
Move your mouse over image or click to enlarge

Phytanic acid

3,7,11,15-Tetramethylhexadecanoic acid

This high purity phytanic acid is ideal as an analytical standard and for use in biological systems. Phytanic acid in animals is derived from phytol, a breakdown product of chlorophyll which is caused by bacteria in the gut of ruminant animals. It is predominantly found in ruminant fats and in some fish. In the metabolism of phytanic acid it must first be converted to pristanic acid via alpha-oxidation, due to the presence of the methyl group at the 3-position, before undergoing betaoxidation. Phytanic acid has been suggested as being linked with prostate cancer but there is now evidence against this view.1 In diseases involving peroxisomal impairment the branched chain fatty acids phytanic acid and pristanic acid accumulate in high amounts due to deficiencies in alpha- and beta-oxidation.2 Phytanic acid is a ligand and transcriptional activator of murine liver fatty acid binding protein thereby causing peroxisome proliferation.3
Cat# Size Price Qty Buy
1195 25 mg £342.19

Additional Information

Property Value or Rating
Product Size 25 mg
Manufacturer Matreya, LLC
Empirical Formula C20H40O2
CAS# 14721-66-5
Formula Weight 312
Solvent none
Source semisynthetic
Purity 97+%
Analytical Methods GC
Solubility chloroform, methanol
Physical Appearance liquid
Storage -20°C
Dry Ice No
Hazardous No
References

1. A. Price et al. “Plasma phytanic acid concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition, Am J Clin Nutr, Vol. 91 pp. 1769-1776, 2010
2. N. Kruska and G. Reiser “Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40” Neurobiology of Disease, Vol. 43(2) pp. 465-472, 2011 
3. C. Wolfrum et al. “Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein” JLR, Vol. 40 pp. 708-714, 1999

Related Documents